Analyst firm Stifel has initiated coverage on sports data giant Genius Sports with a Hold rating, praising its foundational role in the online betting ecosystem but flagging a balanced risk-reward at current levels.
While positioned at the forefront of the small modular reactor (SMR) revolution, NuScale Power remains a pre-revenue manufacturer with significant hurdles to clear before it can deliver on its potential as a growth—and eventual dividend—story for investors.
Amidst legal overhangs and a depressed share price, behavioral health provider Acadia Healthcare is showing signs of a financial inflection point. With activist investors circling and free cash flow on the horizon, some analysts see a classic 'broken growth' story poised for recovery.
Despite beating top-line estimates, PepsiCo faces mounting challenges from volume declines and margin compression. With a $4 billion activist stake and new leadership focus, 2025 is poised as a pivotal transition year for the consumer staples titan.
Shares of the electronic brokerage firm edged higher after reporting strong monthly performance figures, fueled by a sustained rally in U.S. securities trading and significant growth in client activity.
The data analytics firm's quarterly results soared past estimates, fueled by surging government contracts. CEO Alex Karp touts 'iconic' performance while facing renewed scrutiny over the company's role in immigration enforcement.
Amid surging power demands from AI and electrification, NANO Nuclear Energy Inc. (NNE) is attracting bullish investor attention. Analysts point to its microreactor technology as a potential solution for decentralized, high-density energy needs, drawing comparisons to infrastructure giant NextEra Energy's growth trajectory.
The U.S. dollar climbed to a one-week high, buoyed by unexpectedly strong manufacturing activity and hawkish-leaning Federal Reserve commentary. The rally pressured major currency pairs and sent precious metals tumbling, as markets reassessed the timeline for potential interest rate cuts.
A landmark lawsuit filed in Texas federal court targets a California physician for allegedly mailing abortion medication across state lines, testing a new state law that empowers private citizens to act as enforcers and setting up a clash with California's protective 'shield law'.
U.S. equities found firmer ground Tuesday, buoyed by a robust factory activity report. The rally unfolded as investors grow increasingly discerning about AI-related capital expenditures, creating clear winners and losers.
A private survey reveals China's manufacturing sector gained momentum in January, fueled by pre-holiday production and stronger export orders. However, analysts caution that underlying structural imbalances and uneven regional growth continue to challenge the economic outlook.
Raytheon, an RTX business, achieves a critical ballistic flight test for the U.S. Army's new interceptor while securing over $1.2 billion in new defense contracts. These wins solidify its role in next-generation air defense but come as the company's stock trades near record highs, prompting investor scrutiny over future growth.
Amid surging government revenue and public protests over its ICE contracts, Palantir CEO Alex Karp defends the company's controversial surveillance technology, framing it as a safeguard against state overreach rather than an enabler.
The Texas-born travel center giant Buc-ee's is renowned for massive stores and spotless restrooms. But its most disruptive industry practice might be its pay scale, which far exceeds typical convenience store wages and fuels intense competition for jobs.
A new national report reveals Wegmans Food Markets experienced one of the steepest declines in customer satisfaction among major grocers in 2026, as economic pressures reshape shopping priorities toward value and convenience.
The medical device developer Beta Bionics has received a warning letter from the U.S. Food and Drug Administration, a regulatory action stemming from a facility inspection last summer. The company maintains the letter will not disrupt its operations, manufacturing, or the planned launch of its new insulin patch pump.
Asset managers unleashed a historic wave of nearly 1,000 new active ETFs last year, even as a record number shuttered. Despite the high-stakes environment, firms are doubling down, betting on sustained investor demand and advisor adoption to justify the rush.
Abbott Laboratories moves to acquire cancer-testing leader Exact Sciences in a landmark deal, signaling a strategic shift toward high-growth diagnostics while simultaneously restructuring its challenged Nutrition business.
U.S. stocks advanced Monday, buoyed by a surprisingly strong manufacturing report that overshadowed lingering concerns over a partial government shutdown and weak economic data from China. The S&P 500 and Dow Jones Industrial Average both closed higher, led by a rebound in semiconductor and AI-related shares.
The Detroit automaker has held preliminary talks with Xiaomi and other Chinese manufacturers about potential joint ventures to build electric vehicles in the United States, a move already drawing sharp criticism from Washington lawmakers.
